English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1872]
News [4281]
Articles [400]
Editorials [10]
Conferences [107]
elearning [41]
Many people with breast cancer ‘systematically left behind’ due to inaction on inequities and hidden suffering
Many people with breast cancer ‘systematically left behind’ due to inaction on inequities and hidden suffering
Study opens new avenue for immunotherapy drug development
Study opens new avenue for immunotherapy drug development
AI tool predicts responses to cancer therapy using information from each cell of the tumour
AI tool predicts responses to cancer therapy using information from each cell of the tumour
Study explores how relationship with partner impacts breast cancer survivor’s emotional and physical well-being
Study explores how relationship with partner impacts breast cancer survivor’s emotional and physical well-being
Healthy diet lowers heart disease risk in breast cancer survivors
Healthy diet lowers heart disease risk in breast cancer survivors
Lower relapse risk in triple-negative breast cancer with high immune cell levels
Lower relapse risk in triple-negative breast cancer with high immune cell levels
Using generative AI, Insilico Medicine discovers new class of Polθ Inhibitors for BRCA-deficient cancers
Using generative AI, Insilico Medicine discovers new class of Polθ Inhibitors for BRCA-deficient cancers
AI-assisted breast-cancer screening may reduce unnecessary testing
AI-assisted breast-cancer screening may reduce unnecessary testing
ACE inhibitor not protective against heart damage from chemotherapy
ACE inhibitor not protective against heart damage from chemotherapy
AACR 2024: PARP1-selective inhibitor demonstrates early efficacy in breast cancers with DNA repair defects
AACR 2024: PARP1-selective inhibitor demonstrates early efficacy in breast cancers with DNA repair defects
<1...2223242526...429>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top